Accès ouvert
2026
article
OpenAlex
Danwen Zheng, Shiteng Cai, Jian Gao, Sheng Zhao et autres
ABSTRACT Atherosclerosis is a chronic inflammatory disease characterized by defective efferocytosis, which contributes to necrotic core expansion and plaque instability. This dysfunction arises from two key barriers: first, impaired recognition of apoptotic cells due to activation of the CD47–SIRPα immune checkpoint; and …
cn
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Zheyong Huang, Xueyi Weng, Haipeng Tan, Weiyan Li et autres
cn, fr
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Weiyan Li, Xueyi Weng, Juying Qian
Introduction: Atherosclerosis (AS) is a chronic inflammatory disease characterized by lipid accumulation and defective clearance of apoptotic cells in plaques. Traditional LDL-C-lowering therapies such as statins show limited efficacy, as they fail to correct underlying metabolic imbalances. These imbalances cause anti-inflammatory macrophages …
cn
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Xueyi Weng
Background: Inflammatory response is a crucial mechanism in the development and progression of heart failure following ischemic cardiac injury, partly because the delayed clearance of apoptotic cells triggers excessive inflammation. Under normal circumstances, efferocytosis by macrophages mediates the active removal of apoptotic …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Shiteng Cai, Jinfeng Gao, Xueyi Weng, Zhengmin Wang et autres
Atherosclerosis is the leading cause of myocardial infarction and stroke, which is characterized as a chronic inflammatory disease due to the aberrant accumulation of apoptotic cells in the necrotic core. Previous CD47-SIRPα checkpoint blockage strategies based on monoclonal antibodies or nanoparticles have …
cn, us, kr
(code pays fourni par la source)
2025
article
OpenAlex
Xueyi Weng, Weiyan Li, Haipeng Tan, Zhiqing Pang et autres
cn, kr
(code pays fourni par la source)
2024
article
OpenAlex
Hongbo Yang, Lingfeng Luo, Zheyong Huang, Yanan Song et autres
cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Jinfeng Gao, Zhiqing Pang, Qiaozi Wang, Yiwen Tan et autres
CD47-SIRPα axis is an immunotherapeutic target in tumor therapy. However, current monoclonal antibody targeting CD47-SIRPα axis is associated with on-target off-tumor and antigen sink effects, which significantly limit its potential clinical application. Herein, a biomimetic nano-degrader is developed to inhibit CD47-SIRPα axis …
cn, kr
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Haipeng Tan, Weiyan Li, Zhiqing Pang, Xueyi Weng et autres
Efferocytosis, mediated by the macrophage receptor MerTK (myeloid-epithelial-reproductive tyrosine kinase), is a significant contributor to cardiac repair after myocardial ischemia-reperfusion (MI/R) injury. However, the death of resident cardiac macrophages (main effector cells), inactivation of MerTK (main effector receptor), and overexpression of "do …
cn, kr
(code pays fourni par la source)
2023
article
OpenAlex
Jinfeng Gao, Wusiman Yakufu, Hongbo Yang, Yanan Song et autres
Activation of the local renin–angiotensin system (RAS) promotes cardiomyocyte apoptosis and cardiac remodeling after acute myocardial infarction (AMI). As an anti-RAS drug, the effect of Valsartan in the early stage of acute MI is limited by its low drug concentration in the …
cn
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Jinfeng Gao, Zheyong Huang, Qiaozi Wang, Qiyu Li et autres
cn
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Hongbo Yang, Lingfeng Luo, Jiatian Cao, Yanan Song et autres
BACKGROUND: Rapid reperfusion of ST-segment elevation myocardial infarction (STEMI) has been challenging during the coronavirus disease 2019 (COVID-19) outbreak. Whether and to what degree there will be a residual impact when the COVID-19 pandemic has passed is unclear. METHODS: This nationwide retrospective …
cn
(code pays fourni par la source)